Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sisignano, Marco | - |
dc.contributor.author | Angioni, Carlo | - |
dc.contributor.author | Park, Chul-Kyu | - |
dc.contributor.author | Dos Santos, Sascha Meyer | - |
dc.contributor.author | Jordan, Holger | - |
dc.contributor.author | Kuzikov, Maria | - |
dc.contributor.author | Liu, Di | - |
dc.contributor.author | Zinn, Sebastian | - |
dc.contributor.author | Hohman, Stephan W. | - |
dc.contributor.author | Schreiber, Yannick | - |
dc.contributor.author | Zimmer, Bela | - |
dc.contributor.author | Schmidt, Mike | - |
dc.contributor.author | Lu, Ruirui | - |
dc.contributor.author | Suo, Jing | - |
dc.contributor.author | Zhang, Dong-Dong | - |
dc.contributor.author | Schaefer, Stephan M. G. | - |
dc.contributor.author | Hofmann, Martine | - |
dc.contributor.author | Yekkirala, Ajay S. | - |
dc.contributor.author | de Bruin, Natasja | - |
dc.contributor.author | Parnham, Michael J. | - |
dc.contributor.author | Woolf, Clifford J. | - |
dc.contributor.author | Ru-Rong, Ji | - |
dc.contributor.author | Scholich, Klaus | - |
dc.contributor.author | Geisslinger, Gerd | - |
dc.date.available | 2020-02-27T23:44:41Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-11-01 | - |
dc.identifier.issn | 0027-8424 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7696 | - |
dc.description.abstract | Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a severe dose-and therapy-limiting side effect of widely used cyto-statics that is particularly difficult to treat. Here, we report increased expression of the cytochrome-P-450-epoxygenase CYP2J6 and increased concentrations of its linoleic acid metabolite 9,10-EpOME (9,10-epoxy-12Z-octadecenoic acid) in dorsal root ganglia (DRGs) of paclitaxel-treated mice as a model of CIPNP. The lipid sensitizes TRPV1 ion channels in primary sensory neurons and causes increased frequency of spontaneous excitatory postsynaptic currents in spinal cord nociceptive neurons, increased CGRP release from sciatic nerves and DRGs, and a reduction in mechanical and thermal pain hypersensitivity. In a drug repurposing screen targeting CYP2J2, the human ortholog of murine CYP2J6, we identified telmisartan, a widely used angiotensin II receptor antagonist, as a potent inhibitor. In a translational approach, administration of telmisartan reduces EpOME concentrations in DRGs and in plasma and reverses mechanical hypersensitivity in paclitaxel-treated mice. We therefore suggest inhibition of CYP2J isoforms with telmisartan as a treatment option for paclitaxel-induced neuropathic pain. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | NATL ACAD SCIENCES | - |
dc.relation.isPartOf | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - |
dc.subject | POTENTIAL VANILLOID 1 | - |
dc.subject | SOLUBLE EPOXIDE HYDROLASE | - |
dc.subject | MECHANICAL HYPERALGESIA | - |
dc.subject | SENSORY NEURONS | - |
dc.subject | IN-VITRO | - |
dc.subject | TRPV1 | - |
dc.subject | INFLAMMATION | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | METABOLISM | - |
dc.subject | ACTIVATION | - |
dc.title | Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000386608200064 | - |
dc.identifier.doi | 10.1073/pnas.1613246113 | - |
dc.identifier.bibliographicCitation | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, v.113, no.44, pp.12544 - 12549 | - |
dc.identifier.scopusid | 2-s2.0-84993940369 | - |
dc.citation.endPage | 12549 | - |
dc.citation.startPage | 12544 | - |
dc.citation.title | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - |
dc.citation.volume | 113 | - |
dc.citation.number | 44 | - |
dc.contributor.affiliatedAuthor | Park, Chul-Kyu | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | chemotherapy-induced neuropathy | - |
dc.subject.keywordAuthor | neuropathic pain | - |
dc.subject.keywordAuthor | TRPV1 | - |
dc.subject.keywordAuthor | telmisartan | - |
dc.subject.keywordAuthor | oxidized lipids | - |
dc.subject.keywordPlus | POTENTIAL VANILLOID 1 | - |
dc.subject.keywordPlus | SOLUBLE EPOXIDE HYDROLASE | - |
dc.subject.keywordPlus | MECHANICAL HYPERALGESIA | - |
dc.subject.keywordPlus | SENSORY NEURONS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | TRPV1 | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.